NASDAQ:CFRX
Delisted

Contrafect Stock Forecast

etoro logo Buy CFRX
*Your capital is at risk
$0.0500
+0 (+0%)
At Close: Mar 04, 2024

CFRX Performance

FAQ

What is the symbol for ContraFect Corporation Stock and on which exchange is it traded?
The symbol for ContraFect Corporation is CFRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ContraFect Corporation Stock?
ContraFect Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ContraFect Corporation Stock?
ContraFect Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ContraFect Corporation Stock.

What's the current price of ContraFect Corporation Stock?
As of the end of day on the Mar 04, 2024, the price of an ContraFect Corporation (CFRX) share was $0.0500.

What is the 52-week high and low for ContraFect Corporation Stock?
The 52-week high for ContraFect Corporation Stock is $3.95 and the 52-week low is $0.0430.
Click to get the best stock tips daily for free!
ABOUT CONTRAFECT CORPORATION
ContraFect
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE